Definitely not downramping. My first thoughts on seeing the article where, as some posters agreed, that there is one less competitor which makes CVAC even more attractive. Sorry for the confusion.
- Forums
- ASX - By Stock
- IMM
- ovarian cancer drug fails
ovarian cancer drug fails , page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $428.5M |
Open | High | Low | Value | Volume |
28.5¢ | 30.5¢ | 28.0¢ | $833.4K | 2.824M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 388130 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 39940 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 388130 | 0.295 |
8 | 134112 | 0.290 |
8 | 159211 | 0.285 |
15 | 235396 | 0.280 |
7 | 214272 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 39940 | 3 |
0.305 | 116791 | 7 |
0.310 | 295779 | 7 |
0.315 | 160007 | 6 |
0.320 | 130000 | 3 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |